Changes in EQ-5D-Y VAS and US health utility index score in adolescents in the primary efficacy set following exa-cel infusion
| Visit . | Statistic . | EQ-5D-Y VAS . | US health utility index score . |
|---|---|---|---|
| Baseline | n | 12 | 12 |
| Mean (SD) | 78.6 (20.1) | 0.82 (0.25) | |
| Change at month 6 | n | 11 | 11 |
| Mean (SD) | 4.1 (34.9) | 0.10 (0.30) | |
| Change at month 12 | n | 9 | 9 |
| Mean (SD) | 15.8 (20.3) | 0.11 (0.27) | |
| Change at month 24 | n | 7 | 7 |
| Mean (SD) | 10.7 (24.4) | 0.14 (0.26) |
| Visit . | Statistic . | EQ-5D-Y VAS . | US health utility index score . |
|---|---|---|---|
| Baseline | n | 12 | 12 |
| Mean (SD) | 78.6 (20.1) | 0.82 (0.25) | |
| Change at month 6 | n | 11 | 11 |
| Mean (SD) | 4.1 (34.9) | 0.10 (0.30) | |
| Change at month 12 | n | 9 | 9 |
| Mean (SD) | 15.8 (20.3) | 0.11 (0.27) | |
| Change at month 24 | n | 7 | 7 |
| Mean (SD) | 10.7 (24.4) | 0.14 (0.26) |
Baseline is defined as the most recent nonmissing measurement (scheduled or unscheduled) collected before the start of mobilization.
n, number of participants.